Macular edema and thiazolidinediones

Archives of Ophthalmology

Volumn 128, Issue 12, 2010, Pages 1630-1631

  Colucciello, Michael ^a   Ryan, Edwin ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VitreoRetinal Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CREATININE;

CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; HEART EJECTION FRACTION; HEART FUNCTION; HUMAN; LASER COAGULATION; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA EDEMA;

DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; LIGANDS; MACULAR EDEMA; ODDS RATIO; SELECTION BIAS; THIAZOLIDINEDIONES; VISUAL ACUITY;

EID: 78650117791     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.287     Document Type: Note

References (5)

1. Ambrosius WT, Danis RP, Goff DC Jr, et al; ACCORD Study Group. Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy. Arch Ophthalmol. 2010;128(3):312-318.
2. Colucciello M. Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus. Arch Ophthalmol. 2005;123(9):1273-1275. (Pubitemid 41316750)
3. Ryan EH Jr, Han DP, Ramsay RC, et al. Diabetic macular edema associated with glitazone use. Retina. 2006;26(5):562-570. (Pubitemid 44620399)
4. Niemeyer NV, Janney LM. Thiazolidinedione-induced edema. Pharmacotherapy. 2002;22(7):924-929.
5. Fong DS, Contreras R. Glitazone use associated with diabetic macular edema. Am J Ophthalmol. 2009;147(4):583-586, e1.